Cargando…

Modified dose of guselkumab for treatment of pyoderma gangrenosum

Detalles Bibliográficos
Autores principales: Reese, Ashley M., Erickson, Katherine, Reed, Katherine B., Ortega-Loayza, Alex G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818803/
https://www.ncbi.nlm.nih.gov/pubmed/35146098
http://dx.doi.org/10.1016/j.jdcr.2021.11.030
_version_ 1784645911712890880
author Reese, Ashley M.
Erickson, Katherine
Reed, Katherine B.
Ortega-Loayza, Alex G.
author_facet Reese, Ashley M.
Erickson, Katherine
Reed, Katherine B.
Ortega-Loayza, Alex G.
author_sort Reese, Ashley M.
collection PubMed
description
format Online
Article
Text
id pubmed-8818803
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-88188032022-02-09 Modified dose of guselkumab for treatment of pyoderma gangrenosum Reese, Ashley M. Erickson, Katherine Reed, Katherine B. Ortega-Loayza, Alex G. JAAD Case Rep Case Report Elsevier 2022-01-06 /pmc/articles/PMC8818803/ /pubmed/35146098 http://dx.doi.org/10.1016/j.jdcr.2021.11.030 Text en © 2022 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Reese, Ashley M.
Erickson, Katherine
Reed, Katherine B.
Ortega-Loayza, Alex G.
Modified dose of guselkumab for treatment of pyoderma gangrenosum
title Modified dose of guselkumab for treatment of pyoderma gangrenosum
title_full Modified dose of guselkumab for treatment of pyoderma gangrenosum
title_fullStr Modified dose of guselkumab for treatment of pyoderma gangrenosum
title_full_unstemmed Modified dose of guselkumab for treatment of pyoderma gangrenosum
title_short Modified dose of guselkumab for treatment of pyoderma gangrenosum
title_sort modified dose of guselkumab for treatment of pyoderma gangrenosum
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818803/
https://www.ncbi.nlm.nih.gov/pubmed/35146098
http://dx.doi.org/10.1016/j.jdcr.2021.11.030
work_keys_str_mv AT reeseashleym modifieddoseofguselkumabfortreatmentofpyodermagangrenosum
AT ericksonkatherine modifieddoseofguselkumabfortreatmentofpyodermagangrenosum
AT reedkatherineb modifieddoseofguselkumabfortreatmentofpyodermagangrenosum
AT ortegaloayzaalexg modifieddoseofguselkumabfortreatmentofpyodermagangrenosum